Skip to main content
Top
Published in: Archives of Orthopaedic and Trauma Surgery 1/2012

01-01-2012 | Orthopaedic Surgery

Which is more effective in adolescent idiopathic scoliosis surgery: batroxobin, tranexamic acid or a combination?

Authors: Chengshi Xu, Anshi Wu, Yun Yue

Published in: Archives of Orthopaedic and Trauma Surgery | Issue 1/2012

Login to get access

Abstract

Background

Adolescent idiopathic scoliosis surgery is often associated with significant blood loss and blood transfusion. In this clinical trial, the authors investigated the efficacy of reducing blood loss and allogeneic blood transfusion by using batroxobin, tranexamic acid (TXA) and the combination of the two agents.

Methods

80 adolescent patients undergoing scheduled idiopathic scoliosis surgery were randomly divided into four groups to receive 0.9% saline (group A), batroxobin (group B), TXA (group C), and both two agents in the same manner (group D). The amounts of blood loss, transfusion requirements, frozen fresh plasma (FFP) and overall drainage were assessed. The hemoglobin concentration (Hb), hematocrit and platelet counts were recorded preoperative y, postoperatively and on the first operative day. The coagulation parameters were measured meanwhile. Deep vein thrombosis (DVT) was diagnosed by ultrasound.

Results

Blood loss of group B and group C decreased similarly by 35.3 and 42.8% (p = 0.212) compared with group A, while group D was reduced by 64.5, 45.1 and 37.8% compared to group A, B and C, respectively. The amount of allogeneic blood transfusion of group B and group C was comparably reduced by 57.6 and 72.4% compared to group A (p = 0.069), while group D decreased by 94.7, 87.5 and 80.9% compared to group A, B and C. Overall drainage of group B, C and D decreased by 23.0, 45.1 and 67.9% compared with group A, respectively, while group C was reduced by 28.7% compared with group B (p < 0.001). The FFP of group B, C and D was reduced by 63.4, 80.2 and 95.0% as compared with group A, while group C decreased by 45.9% as compared to group B (p = 0.025). There were no urgent coagulation disorders or DVT reported.

Conclusions

In our study, batroxobin and TXA can markedly reduce the blood loss and the transfusion requirements equivalently. However, TXA performs better in minimizing FFP and the overall drainage than batroxobin. The combination seems to achieve best results and was more effective than either of the two drugs alone. No apparent adverse events were detected in these groups.
Literature
1.
go back to reference Guay J, Haig M, Lortie L, Guertin MC, Poitras B (1994) Predicting blood loss in surgery for idiopathic scoliosis. Can J Anaesth 41(9):775–781PubMedCrossRef Guay J, Haig M, Lortie L, Guertin MC, Poitras B (1994) Predicting blood loss in surgery for idiopathic scoliosis. Can J Anaesth 41(9):775–781PubMedCrossRef
2.
go back to reference Eubanks JD (2010) Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg 18(3):132–138PubMed Eubanks JD (2010) Antifibrinolytics in major orthopaedic surgery. J Am Acad Orthop Surg 18(3):132–138PubMed
3.
go back to reference Wong J, El Beheiry H, Rampersaud YR, Lewis S, Ahn H, De Silva Y et al (2008) Tranexamic acid reduces perioperative blood loss in adult patients having spinal fusion surgery. Anesth Analg 107(5):1479–1486PubMedCrossRef Wong J, El Beheiry H, Rampersaud YR, Lewis S, Ahn H, De Silva Y et al (2008) Tranexamic acid reduces perioperative blood loss in adult patients having spinal fusion surgery. Anesth Analg 107(5):1479–1486PubMedCrossRef
4.
go back to reference Elwatidy S, Jamjoom Z, Elgamal E, Zakaria A, Turkistani A, El-Dawlatly A (2008) Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: A prospective, randomized, double-blind, placebo-controlled study. Spine (Phila Pa 1976) 33(24):2577–2580CrossRef Elwatidy S, Jamjoom Z, Elgamal E, Zakaria A, Turkistani A, El-Dawlatly A (2008) Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: A prospective, randomized, double-blind, placebo-controlled study. Spine (Phila Pa 1976) 33(24):2577–2580CrossRef
5.
go back to reference Wan Haslindawani WM, Wan Zaidah A (2010) Coagulation parameters as a guide for fresh frozen plasma transfusion practice: a tertiary hospital experience. Asian J Transfus Sci 4(1):25–27PubMedCrossRef Wan Haslindawani WM, Wan Zaidah A (2010) Coagulation parameters as a guide for fresh frozen plasma transfusion practice: a tertiary hospital experience. Asian J Transfus Sci 4(1):25–27PubMedCrossRef
6.
go back to reference Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Sullivan LJ, Shapiro F (2005) Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology 102(4):727–732PubMedCrossRef Sethna NF, Zurakowski D, Brustowicz RM, Bacsik J, Sullivan LJ, Shapiro F (2005) Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology 102(4):727–732PubMedCrossRef
7.
go back to reference Doi T, Harimaya K, Matsumoto Y, Taniguchi H, Iwamoto Y (2011) Peri-operative blood loss and extent of fused vertebrae in surgery for adolescent idiopathic scoliosis. Fukuoka Igaku Zasshi 102(1):8–13PubMed Doi T, Harimaya K, Matsumoto Y, Taniguchi H, Iwamoto Y (2011) Peri-operative blood loss and extent of fused vertebrae in surgery for adolescent idiopathic scoliosis. Fukuoka Igaku Zasshi 102(1):8–13PubMed
8.
go back to reference Colomina MJ, Bagó J, Vidal X, Mora L, Pellisé F (2009) Antifibrinolytic therapy in complex spine surgery: a case-control study comparing aprotinin and tranexamic Acid. Orthopedics 32(2):91PubMed Colomina MJ, Bagó J, Vidal X, Mora L, Pellisé F (2009) Antifibrinolytic therapy in complex spine surgery: a case-control study comparing aprotinin and tranexamic Acid. Orthopedics 32(2):91PubMed
9.
go back to reference Stocket KF, Todd PW, Bier M (1990) Medical use of snake venum protein. CRC Press, Boston, pp 137–139 Stocket KF, Todd PW, Bier M (1990) Medical use of snake venum protein. CRC Press, Boston, pp 137–139
10.
go back to reference Liu QN, Pang XH, Ke BJ (2005) Hemostatic effect and blood coagulation function of batroxobin in spinal operations. J Fourth Mil Med Univ 26(14):1318–1320 Liu QN, Pang XH, Ke BJ (2005) Hemostatic effect and blood coagulation function of batroxobin in spinal operations. J Fourth Mil Med Univ 26(14):1318–1320
11.
go back to reference Chen SR, Huang CL, Deng ZL, Ke ZY (2004) Effects of batroxobin for injection on blood coagulation in the patients undergoing operation of spine. Theory pract Chin med 14(3):318 Chen SR, Huang CL, Deng ZL, Ke ZY (2004) Effects of batroxobin for injection on blood coagulation in the patients undergoing operation of spine. Theory pract Chin med 14(3):318
12.
go back to reference Bulutcu FS, Ozbek U, Polat B, Yalçin Y, Karaci AR, Bayindir O (2005) Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination? Paediatr Anaesth 15(1):41–46PubMedCrossRef Bulutcu FS, Ozbek U, Polat B, Yalçin Y, Karaci AR, Bayindir O (2005) Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination? Paediatr Anaesth 15(1):41–46PubMedCrossRef
13.
go back to reference Gill JB, Chin Y, Levin A, Feng D (2008) The use of antifibrinolytic agents in spine surgery: a meta-analysis. J Bone Jt Surg Incorporated 90(11):2399–2407CrossRef Gill JB, Chin Y, Levin A, Feng D (2008) The use of antifibrinolytic agents in spine surgery: a meta-analysis. J Bone Jt Surg Incorporated 90(11):2399–2407CrossRef
14.
go back to reference Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C et al (2006) Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology 105(5):1034–1046PubMedCrossRef Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C et al (2006) Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology 105(5):1034–1046PubMedCrossRef
15.
go back to reference Elgafy H, Bransford RJ, McGuire RA, Dettori JR, Fischer D (2010) Blood loss in major spine surgery: are there effective measures to decrease massive hemorrhage in major spine fusion surgery? Spine 35(9 suppl):S47–S56PubMedCrossRef Elgafy H, Bransford RJ, McGuire RA, Dettori JR, Fischer D (2010) Blood loss in major spine surgery: are there effective measures to decrease massive hemorrhage in major spine fusion surgery? Spine 35(9 suppl):S47–S56PubMedCrossRef
16.
go back to reference Schindler E, Photiadis J, Sinzobahamvya N, Döres A, Asfour B, Hraska V (2011) Tranexamic acid: an alternative to aprotinin as antifibrinolytic therapy in pediatric congenital heart surgery. Eur J Cardiothorac Surg 39(4):495–499PubMedCrossRef Schindler E, Photiadis J, Sinzobahamvya N, Döres A, Asfour B, Hraska V (2011) Tranexamic acid: an alternative to aprotinin as antifibrinolytic therapy in pediatric congenital heart surgery. Eur J Cardiothorac Surg 39(4):495–499PubMedCrossRef
17.
go back to reference Neilipovitz DT, Murto K, Hall L, Barrowman NJ, Splinter WM (2001) A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg 93(1):82–87PubMedCrossRef Neilipovitz DT, Murto K, Hall L, Barrowman NJ, Splinter WM (2001) A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg 93(1):82–87PubMedCrossRef
18.
go back to reference Verma K, Errico TJ, Vaz KM, Lonner BS (2010) A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery. BMC surg 10:13PubMedCrossRef Verma K, Errico TJ, Vaz KM, Lonner BS (2010) A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery. BMC surg 10:13PubMedCrossRef
19.
go back to reference Shapiro F, Zurakowski D, Sethna NF (2007) Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for duchenne muscular dystrophy scoliosis. Spine (Phila Pa 1976) 32(20):2278–2283CrossRef Shapiro F, Zurakowski D, Sethna NF (2007) Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for duchenne muscular dystrophy scoliosis. Spine (Phila Pa 1976) 32(20):2278–2283CrossRef
20.
go back to reference Liu JM, Peng HM, Shen JX, Qiu GX (2010) A meta-analysis of the effectiveness and safety of using tranexamic acid in spine surgery. Chin J Surg 48(12):937–942PubMed Liu JM, Peng HM, Shen JX, Qiu GX (2010) A meta-analysis of the effectiveness and safety of using tranexamic acid in spine surgery. Chin J Surg 48(12):937–942PubMed
Metadata
Title
Which is more effective in adolescent idiopathic scoliosis surgery: batroxobin, tranexamic acid or a combination?
Authors
Chengshi Xu
Anshi Wu
Yun Yue
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
Archives of Orthopaedic and Trauma Surgery / Issue 1/2012
Print ISSN: 0936-8051
Electronic ISSN: 1434-3916
DOI
https://doi.org/10.1007/s00402-011-1390-6

Other articles of this Issue 1/2012

Archives of Orthopaedic and Trauma Surgery 1/2012 Go to the issue